Published in Drug Law Weekly, June 29th, 2004
The test, produced by Immunetics, Inc., of Boston, provides an easy-to-use clinical laboratory tool for assessing whether patients have been infected with anthrax.
The Anthrax Quick ELISA test detects antibodies produced during infection with Bacillus anthracis, the bacteria that causes anthrax. The approval shows how cooperative work between government agencies and industry can lead to the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.